Grove Bank & Trust’s Elanco Animal Health ELAN Stock Holding History

Grove Bank & Trust’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4K	Hold	57	–	–	﹤0.01%	820
2026 Q1	$1.36K	Hold	57	–	–	﹤0.01%	800
2025 Q4	$1.29K	Hold	57	–	–	﹤0.01%	817
2025 Q3	$1.15K	Hold	57	–	–	﹤0.01%	802
2025 Q2	$814	Hold	57	–	–	﹤0.01%	826
2025 Q1	$599	Hold	57	–	–	﹤0.01%	824
2024 Q4	$690	Buy	57 +26	+84%	+$340	﹤0.01%	730
2024 Q3	$455	Buy	+31	New	+$432	﹤0.01%	722
2023 Q3	–	Sell	-256	Closed	-$2.58K	–	752
2023 Q2	$2.58K	Hold	256	–	–	﹤0.01%	590
2023 Q1	$2.41K	Buy	+256	New	+$3.02K	﹤0.01%	630

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Grove Bank & Trust's ELAN Position: Q2 2026 in Review

Grove Bank & Trust held its Elanco Animal Health (ELAN) position steady in Q2 2026 at 57 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #820.

Grove Bank & Trust first reported a position in ELAN in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.58K in Q2 2023. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Grove Bank & Trust held 57 shares of Elanco Animal Health worth $1.4K as of Q2 2026.
Grove Bank & Trust left its Elanco Animal Health share count unchanged in Q2 2026.
Elanco Animal Health made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #820 holding.
Grove Bank & Trust first reported a position in Elanco Animal Health in Q1 2023 and has held it in 10 quarters since.
Grove Bank & Trust's Elanco Animal Health position peaked at $2.58K in Q2 2023.
522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.